Abbott Laboratories (ABT)
104.09
-0.78
(-0.74%)
USD |
NYSE |
May 17, 16:00
104.01
-0.08
(-0.08%)
After-Hours: 20:00
Abbott Laboratories Free Cash Flow: 4.923B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 4.923B |
December 31, 2023 | 5.059B |
September 30, 2023 | 4.492B |
June 30, 2023 | 5.488B |
March 31, 2023 | 6.823B |
December 31, 2022 | 7.804B |
September 30, 2022 | 8.541B |
June 30, 2022 | 8.468B |
March 31, 2022 | 8.152B |
December 31, 2021 | 8.648B |
September 30, 2021 | 9.314B |
June 30, 2021 | 8.644B |
March 31, 2021 | 7.609B |
December 31, 2020 | 5.724B |
September 30, 2020 | 4.587B |
June 30, 2020 | 4.564B |
March 31, 2020 | 4.476B |
December 31, 2019 | 4.498B |
September 30, 2019 | 3.814B |
June 30, 2019 | 4.096B |
March 31, 2019 | 4.45B |
December 31, 2018 | 4.906B |
September 30, 2018 | 4.903B |
June 30, 2018 | 4.816B |
March 31, 2018 | 4.966B |
Date | Value |
---|---|
December 31, 2017 | 4.435B |
September 30, 2017 | 3.991B |
June 30, 2017 | 3.154B |
March 31, 2017 | 2.72B |
December 31, 2016 | 2.082B |
September 30, 2016 | 1.811B |
June 30, 2016 | 1.69B |
March 31, 2016 | 1.753B |
December 31, 2015 | 1.856B |
September 30, 2015 | 2.227B |
June 30, 2015 | 2.367B |
March 31, 2015 | 2.284B |
December 31, 2014 | 2.598B |
September 30, 2014 | 2.969B |
June 30, 2014 | 2.29B |
March 31, 2014 | 2.074B |
December 31, 2013 | 2.179B |
September 30, 2013 | 1.974B |
June 30, 2013 | 4.718B |
March 31, 2013 | 5.933B |
December 31, 2012 | 7.519B |
September 30, 2012 | 7.529B |
June 30, 2012 | 7.143B |
March 31, 2012 | 7.631B |
December 31, 2011 | 7.479B |
Free Cash Flow Range, Past 5 Years
3.814B
Minimum
Sep 2019
9.314B
Maximum
Sep 2021
6.286B
Average
5.606B
Median
Free Cash Flow Benchmarks
Stryker Corp | 2.858B |
Boston Scientific Corp | 1.553B |
Intuitive Surgical Inc | 595.80M |
Edwards Lifesciences Corp | 251.20M |
Insulet Corp | 136.70M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 1.025B |
Cash from Investing (Quarterly) | -425.00M |
Cash from Financing (Quarterly) | -1.176B |
Free Cash Flow Per Share (Quarterly) | 0.3584 |
Free Cash Flow to Equity (Quarterly) | 720.00M |
Free Cash Flow to Firm (Quarterly) | 679.04M |
Free Cash Flow Yield | 2.70% |